Global Biodefense Market size to exceed $19 Bn by 2024

Biodefense Market size is set to exceed USD 19 billion by 2024; according to a new research report by Global Market Insights.
 

Technological advancements in biotechnology sector will positively influence the biodefense market growth. Advancements in biotechnology includes developments in detectors that are utilized in assessing the threat against deliberate release of viruses and microbes. This scenario proves beneficial for the biodefense market growth as it surges the demand for vaccines and biothreat identifying agents such as assays as well as reagents in case of any bioterrorism attack.

 

Request Sample Buy NowInquiry Before Buying

 

Government in developed countries is highly aware regarding the impact of bioterrorism attacks on economy that should positively impacts biodefense market growth. Several strategies are implemented including stocking the vaccines and production of bio-threat detection devices to secure the population against bioterrorism attacks. Currently, government in developing countries is also indulging in activities that assure safety against any intentional virus attack. For instance, economies such as India are more susceptible to agricultural bioterrorism and hence, government is undertaking several initiatives to protect the nation as majority of the population relies on agriculture as it is their main occupation. However, low R&D funding by government in developing and underdeveloped economies will hamper the industry growth in forthcoming years.
 

U.S. Biodefense Market Size, By Product, 2017 & 2024 (USD Million)
Biodefense Market

Get more details on this report - Request Free Sample PDF
 

Vaccines segment was valued at USD 7.8 billion in 2017. Rising government initiatives will elevate the demand for superior quality vaccines that are stocked to fight infections caused due to sudden attack of viruses. Recently developed vaccines are highly efficient and create strong immunological response that helps in combating infection creating immunogenic memory. Growing preference for broad spectrum vaccines capable of inducing strong immunogenic response against microbial and viral infections will propel the segmental growth during the forecast period.
 

Browse key industry insights spread across  115 pages with 44 market data tables & 06 figures & charts from the report, “Biodefense Market Size By Product (Vaccines {Anthrax, Smallpox, Botulism}, Biothreat Detection Devices {Samplers, Detectors/Triggering Devices, Identifiers, Assays And Reagents}) Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE), Application Potential, Competitive Market Share & Forecast, 2018 – 2024” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/biodefense-market
 

UK biodefense market will witness 6.3% CAGR over the forecast timeframe. Increasing technological advancements in biotechnology sector will boost the production of vaccines surging the segmental growth in upcoming years. Extensive research and development activities have brought innovations in the bio-threat detection devices that will augment UK biodefense market in near future.
 

Canada biodefense market was valued at USD 349.3 million in 2017 and is expected to have considerable revenue size during the forecast period. Rising government initiatives and funds for taking preventive measures against the bioterrorism attacks will drive the industry growth. Moreover, growing availability of superior quality vaccines and technologically advanced bio-defense devices will trigger the industry growth.
 

Key industry players in biodefense market includes Altimmune, AISense, Emergent BioSolutions, Dynavax Technologies, SIGA Technologies, Elusys Therapeutics, Ichor Medical Systems, DynPort Vaccine Company, Cleveland BioLabs, Bavarian Nordic, Achaogen, Nanotherapeutics, Alnylam Pharmaceuticals, PathSensors and BBI Detection. These prominent players implement several strategic initiatives such as mergers and acquisitions to sustain the industry competition. Receiving FDA approvals for new products also enhances the revenue growth of the companies. For instance, in July 2018, SIGA Technologies received FDA approval for TPOXX that is utilized in the treatment of small pox. This will help the company to achieve sustainable profits as the product is approved and will be marketed to customers.
 

Inquiry Before BuyingRequest Sample
 

Biodefense market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2013 to 2024, for the following segments:

Biodefense Market, By Product (USD Million)

  • Vaccines
    • Anthrax
    • Smallpox
    • Botulism
    • Others
  • Biothreat detection devices
    • Samplers
    • Detectors/triggering devices
    • Identifiers
    • Assays and reagents

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East Asia & Africa
    • South Africa
    • Saudi Arabia
    • UAE

We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X